Temporal Variability of the Salivary Microbiome
Ontology highlight
ABSTRACT:
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| ERR843805_1.fastq.gz | Fastqsanger.gz | |||
| ERR843805_2.fastq.gz | Fastqsanger.gz | |||
| ERR843806_1.fastq.gz | Fastqsanger.gz | |||
| ERR843806_2.fastq.gz | Fastqsanger.gz | |||
| ERR843807_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 140 |
Similar Datasets
Project description:Temporal stability of the salivary microbiome and its association with salivary markers of oxidative stress
| PRJEB13941 | ENA
Project description:Temporal stability of the oral microbiota: A longitudinal study of the dental, tongue, and salivary bacterial consortia
| PRJEB11529 | ENA
Project description:Salivary microbiota in patients with primary sjögren compare to sicca syndrome and healthy controls
| PRJEB29870 | ENA
Project description:Temporal Evolution of Fibroblast Responses Following Salivary Gland Ductal Ligation Injury
| PRJNA1214712 | ENA
Project description:Human Gut and Salivary microbiome Raw sequence reads
| PRJNA938411 | ENA
Project description:Human salivary microbial community diversity in AIDS patients Raw sequence reads
| PRJNA843902 | ENA
Project description:Salivary Oral Microbiome Signatures in Kostmann Syndrome
| PRJEB27123 | ENA
Project description:Extracellular matrix remodeling is a natural response to injury but, excessive extracellular matrix accumulation or fibrosis, is a causative factor in hundreds of diseases that limit organ function and impede regenerative responses. Fibrosis is closely related to inflammation, both of which occur in the salivary glands of patients treated with radiation for head and neck cancers and in patients suffering from the autoimmune condition, Sjögren’s Disease. Despite the known involvement of fibrosis in disease and the inhibitory effects of fibrosis on tissue regeneration, the mechanisms through which fibrosis develops in the salivary gland are poorly understood. Stromal fibroblasts are the primary matrix-producing cells and are known to drive both fibrosis and inflammation. To define the signals produced by fibroblasts in response to injury, we induced a temporary obstructive injury though ligation of the primary submandibular and sublingual salivary gland ducts and then performed single-cell RNA sequencing and pathway analysis at timepoints immediately following the injury. Using bioinformatic approaches, we identified three unique fibroblast groups that dynamically respond to the injury. We characterized the changes in matrisomal and inflammatory gene expression over a 7-day time course and identified the group 2 fibroblasts to be the primary fibrogenic cells, although all groups produced ECM genes. Understanding how fibroblasts respond at early and late injury timepoints along with defining signaling pathways regulated by fibroblasts could lead to a better understanding of the contribution of fibroblast to acute injury responses to facilitate development of therapeutics that minimize fibrosis and promote regenerative gland responses in chronic disease states.
2025-02-28 | GSE287797 | GEO
Project description:Pancreatic cancer is the fourth leading cause of cancer death. Lack of early detection technology for pancreatic cancer invariably leads to a typical clinical presentation of incurable disease at initial diagnosis. Oral fluid (saliva) meets the demand for non-invasive, accessible, and highly efficient diagnostic medium. The level of salivary analytes, such as mRNA and microflora, vary upon disease onset; thus possess valuable signatures for early detection and screening. In this study, we evaluated the performance and translational utilities of the salivary transcriptomic and microbial biomarkers for non-invasive detection of early pancreatic cancer. Two biomarker discovery technologies were used to profile transcriptome in saliva supernatant and microflora in saliva pellet. The Affymetrix Human Genome U133 Plus 2.0 Array was used to discover altered gene expression in saliva supernatant. The Human Oral Microbe Identification Microarray (HOMIM) was used to investigate microflora shift in saliva pellet. Biomarkers selected from both studies were subjected to an independent clinical validation using a cohort of 30 early pancreatic cancer, 30 chronic pancreatitis and 30 healthy matched-control saliva samples. Two panels of salivary biomarkers, including eleven mRNA biomarkers and two microbial biomarkers were discovered and validated for pancreatic cancer detection. The logistic regression model with the combination of three mRNA biomarkers (ACRV1, DMXL2 and DPM1) yielded a ROC-plot AUC value of 0.974 (95% CI, 0.896 to 0.997; P < 0.0001) with 93.3% sensitivity and 90% specificity in distinguishing pancreatic cancer patients from healthy subjects. The logistic regression model with the combination of two bacterial biomarkers (Neisseria elongata and Streptococcus mitis) yielded a ROC-plot AUC value of 0.895 (95% CI, 0.784 to 0.961; P < 0.0001) with 96.4% sensitivity and 82.1% specificity in distinguishing pancreatic cancer patients from healthy subjects. Importantly, the logistic regression model with the combination of four biomarkers (mRNA biomarkers, ACRV1, DMXL2 and DPM1; bacterial biomarker, S. mitis) could differentiate pancreatic cancer patients from all non-cancer subjects (chronic pancreatitis and healthy control), yielding a ROC-plot AUC value of 0.949 (95% CI, 0.877 to 0.985; P < 0.0001) with 92.9% sensitivity and 85.5% specificity. This study comprehensively compared the salivary transcriptome and microflora between pancreatic cancer and control subjects. We have discovered and validated eleven mRNA biomarkers and two microbial biomarkers for early detection of pancreatic cancer in saliva. The logistic regression model with four salivary biomarkers can detect pancreatic cancer specifically without the complication of chronic pancreatitis. This is the first report demonstrating the value of multiplex salivary biomarkers for the non-invasive detection of a high impact systemic cancer. Keywords: Salivary biomarker, pancreatic cancer, early detection, salivary transcriptome, salivary microflora
2008-12-31 | GSE14245 | GEO